FDA takes action to ease neonatal drug shortage
WASHINGTON -- Federal health regulators are allowing imports from overseas of critical intravenous drugs used to nourish premature infants, amid a shortage that has affected hospitals nationwide. The Food and Drug Administration said Wednesday new supplies of drugs used in total parenteral nutrition, a ubiquitous hospital staple, will be available to U.S. patients this week. The injectable formula is used to feed newborn infants, cancer patients and other vulnerable groups who are unable to eat or drink by mouth. "If they cannot eat anything by mouth they have to be provided intravenous nutrition or they'll starve to death in a very short period of time," said Jay Mirtallo, professor of clinical pharmacy at Ohio State University.
- As Retail Clinics Surge, Quality Metrics MIA
- Providers' Push to Consolidate Roils Payers
- Medicare Cost, Quality Data Tools Weak, Says GAO
- RN Named Chief Patient Experience Officer
- No Employee Satisfaction, No Patient-Centered Culture
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- Population Health Pays Off for NY Collaborative
- How Simple Data Analytics is Driving Physician Incentives
- In PCMH, the 'P' is Not for 'Physician'
- AMA Pushes Lame Duck Congress for SGR Repeal